The World Health Organization has emphasized the importance of early and accurate diagnosis of bacterial infections. An ideal diagnostic tool would possess high speed, high throughput, accuracy, low cost and simplicity of use for the clinical laboratory or bedside applications.

Diagnostic tools that possess all these properties currently do not exist. To address this knowledge gap, in the BUG-ID consortium, seven European universities, one research institute, one hospital and six private companies have teamed up. Our consortium will train 15 doctoral candidates with skills in interdisciplinary research, spanning from nanotechnology and materials science to molecular microbiology, biochemistry, infection medicine to AI-based data analysis. 

Find more information here.